Neuroprotective Potential of Vaccination Against SARS-CoV-2 in Nonhuman Primates

NIH Pandemic-Era Grants

Pandemic Era Grants

2023

Document text

Principal Investigator: JAMES B DAUNAIS
Organization: WAKE FOREST UNIVERSITY HEALTH SCIENCES
Fiscal Year: 2023
Award: $426,250
Funding agency: National Institute of Neurological Disorders and Stroke

This project will determine the temporal and anatomic profile of COVID-19 related changes in brain function and neurobiology and whether identified changes relate to brain alterations seen in Alzheimer’s Disease (AD). Although COVID-19 is a novel coronavirus disease, studies have reported that brain structure and function is significantly impacted in humans who become infected and subsequently exhibit cognitive deficits. While it is unclear whether COVID-19 may be a causative or exacerbating factor for dementia, a recent study reported that AD-associated peripheral biomarkers such as t-tau, p-tau181, GFAP, and NfL were elevated in hospitalized COVID+ patients without a history of dementia. These markers correlated with severity of COVID-19 illness (Frontera et al., 2021). While many of the neurological symptoms seen in COVID-19 patients are also exhibited in AD patients, it remains unclear whether any of the markers were present prior to infection or changed because of infection. The ability to identify changes in brain function and neurobiological markers of neurodegeneration early in the COVID-19 disease process would help illuminate whether specific brain regions are more vulnerable than others to infection. Using a cross-sectional experimental design, we recently applied magnetoencephalography (MEG) in nonhuman primates to test the efficacy of a novel COVID vaccine to record resting state (RS) brain function in vaccinated and unvaccinated animals after infection with SARS-CoV-2 and found significant differences in brain function between the groups. We will extend these findings in vervet monkeys to record RS and sensory gating (SG) brain function PRIOR to vaccination and infection. Baseline brain activity will confirm whether any of the changes we detected in the cross-sectional study exist at baseline prior to vaccination and infection. We will measure RS and SG brain function AFTER vaccination with the Moderna mRNA vaccine or a novel psoralen inactivated virus and subsequent challenge with live virus. This will allow us to identify the temporal and anatomical profile of changes in brain activity that result from COVID infection early in the infection process. We will also collect biological samples including CSF and blood pre- and post-infection to track levels of peripheral biomarkers of neurodegenerative diseases that result from COVID infection. We will identify changes in RS and SG brain function to correlate changes in specific brain regions that underlie self-reports of cognitive deficits including ‘foggy brain’ and confusion related to “long COVID” that COVID+ patients report during the recovery period. We will utilize a simple bimanual coordination task as a behavioral measure with which to correlate changes in brain function and markers of neurodegeneration. The ability to capture baseline measures of brain function, behavioral measures and biomarkers prior to infection and vaccination and then early in the disease process will provide valuable insight into which brain regions and neurodegenerative markers may be most impacted by the disease process.

Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV vaccine><3-arm study><AD dementia><Acceleration><Address><Adverse Experience><Adverse event><Ageusia><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's disease patient><Alzheimer's patient><Alzheimers Dementia><Amentia><Ammon Horn><Amygdala><Amygdaloid Body><Amygdaloid Nucleus><Amygdaloid structure><Anatomic Sites><Anatomic structures><Anatomy><Animals><Anterior><Anxiety><Area><Astroprotein><Auditory><B.1.617.2><Behavioral><Biological><Biological Markers><Blood><Blood Reticuloendothelial System><Brain><Brain Nervous System><Brain region><COVID><COVID diagnosis><COVID disease severity><COVID infected patient><COVID patient><COVID positive patient><COVID severity><COVID-19><COVID-19 affected><COVID-19 consequence><COVID-19 detection><COVID-19 disease severity><COVID-19 effect><COVID-19 exposure><COVID-19 impact><COVID-19 impacted><COVID-19 infected patient><COVID-19 infection><COVID-19 patient><COVID-19 positive patient><COVID-19 severity><COVID-19 vaccination><COVID-19 vaccine><COVID-19 virus><COVID-19 virus infection><COVID19><COVID19  detection><COVID19 disease severity><COVID19 infection><COVID19 patient><COVID19 positive patient><COVID19 severity><COVID19 vaccination><COVID19 vaccine><COVID19 virus><CV-19><CV19><Cell Communication and Signaling><Cell Signaling><Cephalalgia><Cephalgia><Cephalodynia><Cercopithecus tantalus><CoV disease><CoV emergence><CoV-2><CoV2><Cognitive deficits><Confusion><Confusional State><Cornu Ammonis><Crab-Eating Macaque><Crab-Eating Monkey><Cranial Pain><Cross Sectional Analysis><Cross-Sectional Analyses><Cross-Sectional Studies><Cross-Sectional Survey><Cynomolgus Monkey><Cynomolgus macaque><Data><Degenerative Neurologic Diseases><Degenerative Neurologic Disorders><Delta variant><Dementia><Development><Disease><Disease Frequency Surveys><Disorder><Dizziness><Dose><Encephalon><Exhibits><Experimental Designs><GFA-Protein><GFAP><Glial Fibrillary Acid Protein><Glial Fibrillary Acidic Protein><Glial Intermediate Filament Protein><Head Pain><Headache><Hippocampus><History><Hospital Admission><Hospitalization><Human><Inactivated Vaccines><Inactivated Virus Vaccine><Infection><Intracellular Communication and Signaling><Killed Vaccines><Long COVID><Long COVID-19><Long coronavirus disease><Long coronavirus disease 2019><M fascicularis><M. fascicularis><MEG imaging><MR Imaging><MR Tomography><MRI><MRIs><MT-bound tau><Macaca><Macaca fascicularis><Macaque><Magnetic Resonance Imaging><Magnetoencephalography><Manuals><Measurement><Measures><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Mental Confusion><Mental Depression><Modern Man><Monkeys><NMR Imaging><NMR Tomography><Nature><Nerve Degeneration><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurobiology><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic><Neurologic Degenerative Conditions><Neurologic Manifestations><Neurologic Signs and Symptoms><Neurologic Symptoms><Neurological><Neurological Manifestations><Neurological Signs and Symptoms><Neuron Degeneration><Nuclear Magnetic Resonance Imaging><Olfaction><Pathology><Patient Self-Report><Patients><Peripheral><Primary Senile Degenerative Dementia><Process><RNA vaccine><RNA-based vaccine><Recording of previous events><Recovery><Regimen><Reporting><Rest><Retrospective Studies><Risk><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 B.1.617.2><SARS-CoV-2 delta><SARS-CoV-2 detection><SARS-CoV-2 disease severity><SARS-CoV-2 exposure><SARS-CoV-2 infected patient><SARS-CoV-2 infection><SARS-CoV-2 patient><SARS-CoV-2 positive patient><SARS-CoV-2 severity><SARS-CoV-2 vaccination><SARS-CoV-2 vaccine><SARS-CoV2><SARS-CoV2 exposure><SARS-CoV2 infection><SARS-CoV2 vaccine><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 vaccine><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Self-Report><Serum Markers><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 exposure><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 vaccination><Severe acute respiratory syndrome coronavirus 2 vaccine><Severe acute respiratory syndrome related corona virus 2><Signal Transduction><Signal Transduction Systems><Signaling><Smell><Smell Perception><Structure><Symptoms><Thalamic structure><Thalamus><Thick><Thickness><Vaccinated><Vaccination><Vaccines><Vervet Monkey><Viral Burden><Viral Load><Viral Load result><Virus><Wuhan coronavirus><Zeugmatography><amygdaloid nuclear complex><behavior measurement><behavioral measure><behavioral measurement><bio-markers><biologic><biologic marker><biological signal transduction><biomarker><brain based><brain fog><brain size><chronic COVID><chronic COVID-19><chronic novel coronavirus disease 2019><cognitive defects><corona virus disease><corona virus disease 2019><corona virus disease 2019 vaccine><corona virus emergence><coronavirus diagnosis><coronavirus disease><coronavirus disease 2019><coronavirus disease 2019 consequence><coronavirus disease 2019 detection><coronavirus disease 2019 disease severity><coronavirus disease 2019 effect><coronavirus disease 2019 exposure><coronavirus disease 2019 impact><coronavirus disease 2019 infected patient><coronavirus disease 2019 infection><coronavirus disease 2019 patient><coronavirus disease 2019 positive patient><coronavirus disease 2019 severity><coronavirus disease 2019 vaccination><coronavirus disease 2019 vaccine><coronavirus disease 2019 virus><coronavirus disease diagnosis><coronavirus disease infected patient><coronavirus disease patient><coronavirus disease positive patient><coronavirus disease severity><coronavirus disease-19><coronavirus disease-19 impact><coronavirus disease-19 patient><coronavirus disease-19 vaccine><coronavirus disease-19 virus><coronavirus emergence><coronavirus infectious disease-19><coronavirus patient><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><depression><detect COVID-19><detect COVID19><detect SARS-CoV-2><detect severe acute respiratory syndrome coronavirus 2><developmental><diagnosed with COVID><diagnosed with coronavirus><diagnosed with coronavirus disease><efficacy testing><emergent CoV><emergent corona virus><emergent coronavirus><emerging CoV><emerging corona virus><emerging coronavirus><executive control><executive function><exposure to COVID-19><exposure to SARS-CoV-2><exposure to SARS-CoV2><exposure to Severe acute respiratory syndrome coronavirus 2><exposure to coronavirus disease 2019><gray matter><hCoV19><head ache><hippocampal><histories><improved><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><information processing><insight><interest><long haul COVID><long haul COVID-19><long haul coronavirus disease><long haul coronavirus disease 2019><long-hauler COVID><long-hauler COVID-19><long-hauler coronavirus disease 2019><long-hauler syndrome><long-term COVID><long-term COVID-19><long-term coronavirus disease><long-term coronavirus disease 2019><longterm COVID><longterm COVID-19><longterm coronavirus disease><longterm coronavirus disease 2019><mRNA vaccine><mRNA-based vaccine><magnetoencephalographic imaging><microtubule bound tau><microtubule-bound tau><nCoV><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><nCoV2><neural degeneration><neural manifestation><neurobiological><neurodegeneration><neurodegenerative><neurodegenerative illness><neurological degeneration><neuronal degeneration><neuroprotection><neuroprotective><new CoV><new corona virus><new coronavirus><non vaccinated><non-human primate><nonhuman primate><not vaccinated><novel><novel CoV><novel corona virus><novel coronavirus><odor perception><olfactory perception><patient infected with COVID><patient infected with COVID-19><patient infected with SARS-CoV-2><patient infected with coronavirus disease><patient infected with coronavirus disease 2019><patient infected with severe acute respiratory syndrome coronavirus 2><patient living with Alzheimer's disease><patient suffering from Alzheimer's disease><patient with Alzheimer's><patient with Alzheimer's disease><patient with COVID><patient with COVID-19><patient with COVID19><patient with SARS-CoV-2><patient with coronavirus disease><patient with coronavirus disease 2019><patient with severe acute respiratory distress syndrome coronavirus 2><post COVID syndrome><post COVID-19 syndrome><post acute COVID syndrome><post acute COVID-19><post acute COVID-19 syndrome><post acute SARS-CoV-2><post acute coronavirus disease 2019><post acute coronavirus disease 2019 syndrome><post acute coronavirus disease syndrome><post acute severe acute respiratory syndrome coronavirus 2><post coronavirus disease 2019 syndrome><post coronavirus disease syndrome><post-acute phases of COVID-19><primary degenerative dementia><senile dementia of the Alzheimer type><sensory gating><severe acute respiratory syndrome coronavirus 2 B.1.617.2><severe acute respiratory syndrome coronavirus 2 detection><severe acute respiratory syndrome coronavirus 2 disease severity><severe acute respiratory syndrome coronavirus 2 infected patient><severe acute respiratory syndrome coronavirus 2 patient><severe acute respiratory syndrome coronavirus 2 positive patient><severe acute respiratory syndrome coronavirus 2 severity><substantia grisea><taste loss><tau><tau Proteins><tau factor><thalamic><three-arm study><unvaccinated><vaccinate against COVID-19><vaccinate against COVID19><vaccinate against SARS-CoV-2><vaccinate against coronavirus disease 2019><vaccinate against severe acute respiratory syndrome coronavirus 2><vaccination adverse event><vaccination against COVID-19><vaccination against COVID19><vaccination against SARS-CoV-2><vaccination against Severe acute respiratory syndrome coronavirus 2><vaccination against coronavirus disease 2019><vaccination associated adverse event><vaccination induced adverse event><vaccination related adverse event><vaccine adverse event><vaccine against 2019-nCov><vaccine against SARS-CoV-2><vaccine against SARS-CoV2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine associated adverse event><vaccine for novel coronavirus><vaccine induced adverse event><vaccine related adverse event><τ Proteins>